Pagetoid Reticulosis is a type of skin cancer called mycosis fungoides. It causes patches or plaques on the skin, often in the groin or armpits. It's caused by an abnormal growth of skin cells inside the top layer of the skin.
Every report comes from a Lived member, sent anonymously.
Have you tried Radiation Therapy for Pagetoid Reticulosis?
Pagetoid reticulosis is a rare, slow-growing form of skin lymphoma. It is a variant of mycosis fungoides, the most common cutaneous T-cell lymphoma, a cancer in which T cells (a type of white blood cell) become abnormal and collect in the skin. In pagetoid reticulosis, those cells gather in the outermost layer of skin and usually stay there. The usual form, also called Woringer-Kolopp disease, appears as a single red, scaly or thickened patch or plaque, most often on a hand, foot or lower leg. It often causes no symptoms beyond its appearance, though some people notice mild itching, and it enlarges very slowly over years. This localized form has a very good outlook. A widespread form with many lesions, known as Ketron-Goodman disease, is far rarer, behaves more aggressively and needs a different level of care.
What causes pagetoid reticulosis is not known, and no exposure, habit or inherited risk has been shown to lead to it. It is not an infection and does not develop because of anything a person did to their skin. It has been reported in both children and adults and appears to be somewhat more common in men, with roughly two men affected for every woman. Because so few cases have been described, researchers have not been able to identify risk factors in the way they can for more common conditions.
A skin biopsy is the only way to confirm the diagnosis. A small piece of the patch is removed, usually after numbing the skin, and a pathologist looks for abnormal T cells scattered through the top layer of skin. Special stains (immunohistochemistry) show which proteins the cells carry, which helps separate pagetoid reticulosis from other forms of T-cell lymphoma and from inflammatory rashes. The main challenge is thinking of it at all. The patch closely resembles eczema, psoriasis or a fungal infection, so people are often treated for those conditions first. In one review of published cases, the average time from the first skin change to diagnosis was about eight years. A dermatologist may examine the patch with a handheld magnifier (dermoscopy) for clues, but this cannot replace a biopsy. Once the diagnosis is made, the doctor checks the rest of the skin and the lymph nodes to make sure the disease is limited to one area.
Because the condition is so rare, there are no formal treatment guidelines, and what is known comes from case reports and small series rather than clinical trials. For a single localized patch, the aim is to clear it completely, and the main choices are local treatments. Radiation therapy aimed only at the affected skin is the most widely used option. In pooled published cases, everyone treated with radiation alone cleared without the disease returning, although relapses after radiation have occasionally been reported. It usually involves a series of short sessions and can leave temporary redness and lasting color change in the treated skin. Surgical removal cured most reported patches where the location allowed it, at the cost of a scar, which matters more on the hands, feet and face. Photodynamic therapy, in which a light-activated cream is applied and then exposed to a special light, is a less invasive choice sometimes used for children, younger adults or cosmetically sensitive areas. Treatments applied to the skin are simpler but less reliable. Strong steroid creams alone cleared only about a quarter of reported cases, though they can help some people. Other options include mechlorethamine (also called nitrogen mustard), a chemotherapy medicine applied to the skin, and light therapy with ultraviolet light. The choice depends on where the patch is, its size, age, cost and access to treatment, and personal preference. The rare widespread form is managed by a team, often a dermatologist and a cancer specialist, and may need medicines that work throughout the body.
For most people with the localized form, pagetoid reticulosis is a manageable skin problem rather than a threat to life. In a review of published cases, about four in five people went into complete remission, meaning no visible disease remained, over an average follow-up of three to four years. About one in ten saw it come back, sometimes more than once, even after radiation. Because recurrence is possible and the long-term behavior of this rare condition is not fully mapped, follow-up visits with a dermatologist continue after treatment. These visits check the treated area and the rest of the skin. Day to day, the patch rarely limits activity, though a plaque on the sole or palm can be uncomfortable, and the appearance of the skin or a scar can matter to people. A relapsing or hard-to-treat patch can weigh more heavily on quality of life, and it is reasonable to discuss other options if the first treatment does not work. The outlook for the widespread Ketron-Goodman form is less favorable, and its course needs closer specialist follow-up.
See a dermatologist about a single red, scaly or thickened patch that persists for months or slowly grows despite treatment for eczema, psoriasis or a fungal infection, and ask whether a biopsy is needed. After a diagnosis, contact your care team promptly if the treated patch returns, a new patch or lump appears elsewhere on the skin, or you notice swollen lymph nodes, since these can signal recurrence or spread and should be checked.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Pagetoid Reticulosis is like, what's helped you, or ask the community a question.